Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Related Citations for PubMed (Select 23233555)

1.

Gaucher disease and other storage disorders.

Grabowski GA.

Hematology Am Soc Hematol Educ Program. 2012;2012:13-8. doi: 10.1182/asheducation-2012.1.13. Review.

2.

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.

Aerts JM, Kallemeijn WW, Wegdam W, Joao Ferraz M, van Breemen MJ, Dekker N, Kramer G, Poorthuis BJ, Groener JE, Cox-Brinkman J, Rombach SM, Hollak CE, Linthorst GE, Witte MD, Gold H, van der Marel GA, Overkleeft HS, Boot RG.

J Inherit Metab Dis. 2011 Jun;34(3):605-19. doi: 10.1007/s10545-011-9308-6. Epub 2011 Mar 29. Review.

3.

Newborn screening for lysosomal storage disorders.

Nakamura K, Hattori K, Endo F.

Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):63-71. doi: 10.1002/ajmg.c.30291. Epub 2011 Feb 10. Review.

PMID:
21312327
4.

[Lysosomes and lysosomal storage diseases].

Germain DP.

J Soc Biol. 2002;196(2):127-34. Review. French.

PMID:
12360741
5.

New prospects for the treatment of lysosomal storage diseases.

Schiffmann R, Brady RO.

Drugs. 2002;62(5):733-42. Review.

PMID:
11929328
6.

[Treatment prospects of lysosomal storage disorders].

Reismann P, Tulassay Z.

Orv Hetil. 2008 Jun 22;149(25):1171-9. doi: 10.1556/OH.2008.28382. Review. Hungarian.

PMID:
18547894
7.

Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.

Zhang XS, Brondyk W, Lydon JT, Thurberg BL, Piepenhagen PA.

J Inherit Metab Dis. 2011 Jun;34(3):795-809. doi: 10.1007/s10545-011-9285-9. Epub 2011 Mar 17.

PMID:
21416197
8.

Newborn screening of lysosomal storage disorders.

Marsden D, Levy H.

Clin Chem. 2010 Jul;56(7):1071-9. doi: 10.1373/clinchem.2009.141622. Epub 2010 May 20. Review.

9.

Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.

Hoffmann B, Mayatepek E.

Neuropediatrics. 2005 Oct;36(5):285-9. Review.

PMID:
16217702
10.

Treatment perspectives for the lysosomal storage diseases.

Grabowski GA.

Expert Opin Emerg Drugs. 2008 Mar;13(1):197-211. doi: 10.1517/14728214.13.1.197 . Review.

PMID:
18321157
11.

Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease.

Sawkar AR, D'Haeze W, Kelly JW.

Cell Mol Life Sci. 2006 May;63(10):1179-92. Review.

PMID:
16568247
12.

Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly.

vom Dahl S, Mengel E.

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):619-28. doi: 10.1016/j.bpg.2010.09.001. Review.

PMID:
20955964
13.

[Lysosomal storage diseases].

Manger B.

Z Rheumatol. 2010 Aug;69(6):527-38. doi: 10.1007/s00393-010-0627-z. Review. German.

PMID:
20532791
14.

Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.

Hopkins PV, Campbell C, Klug T, Rogers S, Raburn-Miller J, Kiesling J.

J Pediatr. 2015 Jan;166(1):172-7. doi: 10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18.

PMID:
25444528
15.

Lysosomal storage disorders in Thailand: the Siriraj experience.

Wasant P, Wattanaweeradej S, Raksadawan N, Kolodny EH.

Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:54-8.

PMID:
8629143
16.

Gaucher disease: Perspectives on a prototype lysosomal disease.

Zhao H, Grabowski GA.

Cell Mol Life Sci. 2002 Apr;59(4):694-707. Review.

PMID:
12022475
17.

[Enzyme replacement therapy for lysosomal storage disorders].

Valayannopoulos V, Brassier A, Chabli A, Caillaud C, Lemoine M, Odent T, Arnoux JB, de Lonlay P.

Arch Pediatr. 2011 Oct;18(10):1119-23. doi: 10.1016/j.arcped.2011.07.002. Epub 2011 Aug 27. Review. French.

PMID:
21873040
18.

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Platt FM, Boland B, van der Spoel AC.

J Cell Biol. 2012 Nov 26;199(5):723-34. doi: 10.1083/jcb.201208152. Review.

19.

Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.

Mechtler TP, Stary S, Metz TF, De Jesús VR, Greber-Platzer S, Pollak A, Herkner KR, Streubel B, Kasper DC.

Lancet. 2012 Jan 28;379(9813):335-41. doi: 10.1016/S0140-6736(11)61266-X. Epub 2011 Nov 29.

PMID:
22133539
20.

Substrate reduction therapy.

Platt FM, Jeyakumar M.

Acta Paediatr Suppl. 2008 Apr;97(457):88-93. doi: 10.1111/j.1651-2227.2008.00656.x. Review.

PMID:
18339196
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk